Theme: Interactive Multidisciplinary Case Discussions
Date:  13 March, 2021 (Sat), 09:00-13:00 HKT

Topic 1: Precision Sarcoma Care
Presenter: Dr. Jay S. Wunder, Canada


Topic 2: NTRK-fusion sarcomas – case presentation and pathological diagnosis
Presenter: Prof. Kenneth Tou En Chang, Head of Department, Department of Pathology and Laboratory Medicine, KK Women’s and Children’s Hospital, Singapore

NTRK fusion sarcomas are rare but important to diagnose as TRK inhibitors may be effective in their treatment. In this presentation, we discuss an adolescent who presented with a sarcoma harbouring a novel NTRK gene fusion. The tumour was initially responsive to targeted treatment but subsequently developed a resistance mutation. In addition, we will discuss the different diagnostic techniques that can be used in the clinical setting to diagnose NTRK fusion sarcomas.

Topic 3: Interactive Multidisciplinary Case Discussions


Theme: Gastrointestinal Stromal Tumour (GIST)

Topic 1:The Advances in the Management of Later-line GIST-implications and applications of New Target Therapy
Speaker: Prof. Sebastian Bauer, Germany

Topic 2: Surgical advances in the management of GIST — from MIS to scarless surgery
Speaker: Prof. Shannon Melissa Chan, CUHK


Theme: Adolescent & Young Adults Oncology (AYA Oncology)

Topic 1: INAUGURAL YOANNA WONG LECTURE – The Importance and Relevance of Dedicated AYA Oncology Care
Speaker: Dr. Jeremy Lewin, Australia   

Topic 2: Addressing the unique needs of AYA cancer survivors in Hong Kong: Current gaps and opportunities
Speaker: Prof. Yin-Ting Cheung, CUHK


Theme: Tenosynovial Giant Cell Tumour (TGCT)

Topic 1: PVNS/TGCT – When to treat and how to treat?
Speaker : Dr. Chao-Ming Chen, Taiwan

Topic 2: Practical aspects of systemic therapies in the management of PVNS/TGCT
Speaker: Dr. Tom Wei-Wu Chen, Taiwan

Meet Our Speakers

Dr. Tom Wei-Wu CHEN

Tom Wei-Wu Chen, MD
Attending physician
Department of Oncology
National Taiwan University Hospital
Taipei, Taiwan

Dr. Tom W. Chen is currently an attending physician at the Department of Oncology, National Taiwan University Hospital (NTUH) in Taipei, Taiwan. Dr. Chen received internal medicine training followed by a fellowship course as a medical oncologist in NTUH. Afterwards, he joined Drug Development Program (DDP) in Princess Margaret Cancer Centre in Toronto, Canada as a clinical fellow to study early phase clinical trials with Dr. Lillian Siu and Dr. Phil Bedard. During his stay in Princess Margaret, he gained more experience with next-generation sequencing and precision medicine, as well as interest in sarcoma patients.